Figures & data
Figure 1. Low BRCA2 mRNA expression is associated with better survival in HGSOC. BRCA2 mRNA expression and PFS (a) and OS (b) in 563 HGSOC patients.
Table 1. Multivariate survival analysis in 563 OC patients.
Acta Oncologica
Volume 60, 2021 - Issue 2
LETTERS TO THE EDITOR: CLINICAL ONCOLOGY
Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort
Irina Tsibulaka Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria
https://orcid.org/0000-0001-6795-3015View further author information
https://orcid.org/0000-0001-6795-3015View further author information, , , , , , & show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.